Bar Ilan University, Ramat Gan, Israel.
Peres Academic Center, Rehovot, Israel.
Isr J Health Policy Res. 2022 Jan 31;11(1):6. doi: 10.1186/s13584-022-00519-8.
To present the response of the Israel National Transplantation Center (NTC) to the evolving challenge of COVID-19, the impact on deceased organ donation and living organ kidney donation during 2020, and resultant policy and ethical implications.
Data collected included (i) for deceased donors, the total number of potential organ donors, if hospitalized in ICU or general ward, cause of death, number of family authorizations and refusals, number of actual donors, number of organs transplanted/donor and total number of transplants performed; (ii) for living-kidney-donors (related or altruistic), the number of procedures performed; and (iii) the number of patients registered on the national organ waiting-list.
Following the first case (February 2020), deceased organ donation continued uninterrupted. The total number of potential donors was similar to 2019 (181 vs. 189). However, the number of families approached for donation decreased significantly (P = 0.02). This may be attributed to COVID-19-imposed limitations including fewer brain death determinations due to limited possibilities for face-to-face donor coordinator-donor family interactions providing emotional support and visual explanations of the medical situation. Fewer donors were admitted to ICU (P = 0.1) and the number of organs retrieved/donor decreased (3.8/donor to 3.4/donor). The overall result was a decrease of 24.2% in the number of transplant procedures (306 vs. 232). Living kidney donation, initially halted, resumed in May and the total number of procedures increased compared to 2019 due to a significant increase in altruistic donations (P < 0.0001), while the number of related-living donations decreased.
This study of organ donation during a crisis has informed the introduction of policy changes in the NTC including the necessity to mobilize rapidly a "war room", the use of innovative virtual tools for contact-less communication, and the importance of cooperation with hospital authorities in allocating scarce health-care resources. Finally, the pandemic highlighted and intensified ethical considerations, such as under what circumstances living kidney donation be continued in the face of uncertainty, and what information to provide to altruistic donors regarding a prospective recipient, in particular whether all options for related living donation have been exhausted. These should be addressed now.
介绍以色列国家移植中心(NTC)应对 COVID-19 不断变化的挑战的情况,包括 2020 年对已故器官捐献和活体器官肾捐献的影响,以及由此产生的政策和伦理影响。
收集的数据包括:(i)已故捐献者,潜在器官捐献者总数,如果在 ICU 或普通病房住院,死亡原因,家属同意和拒绝的数量,实际捐献者数量,移植器官数量/捐献者和总移植数量;(ii)活体肾捐献者(相关或利他),手术数量;以及(iii)国家器官等待名单上登记的患者数量。
首例病例(2020 年 2 月)发生后,已故器官捐献继续进行,未受影响。潜在捐献者总数与 2019 年相似(181 对 189)。然而,寻求捐献的家庭数量显著减少(P=0.02)。这可能归因于 COVID-19 实施的限制,包括由于面对面的捐献协调员与捐献者家庭之间的互动减少,导致进行脑死亡确定的可能性降低,从而无法提供情感支持和对医疗状况的直观解释。更少的捐献者被收入 ICU(P=0.1),并且每个捐献者取出的器官数量减少(3.8/捐献者降至 3.4/捐献者)。结果导致移植手术数量减少 24.2%(306 对 232)。活体肾捐献最初停止,于 5 月恢复,由于利他捐赠显著增加(P<0.0001),与 2019 年相比,手术总数增加,而相关活体捐献的数量减少。
本研究对危机期间的器官捐献进行了分析,为 NTC 引入政策变革提供了信息,包括迅速动员“作战室”的必要性,使用创新的虚拟工具进行无接触式沟通,以及与医院当局合作分配稀缺医疗资源的重要性。最后,大流行凸显并加剧了伦理考虑,例如在不确定的情况下活体肾捐献应在何种情况下继续进行,以及应向利他主义捐献者提供有关预期受者的哪些信息,特别是是否已用尽所有相关活体捐献的选项。现在应该解决这些问题。